Immunic (NASDAQ:IMUX) Given Buy Rating at D. Boral Capital
Immunic (NASDAQ:IMUX – Get Free Report)‘s stock had its “buy” rating restated by analysts at D. Boral Capital in a report issued on Thursday,Benzinga reports. They presently have a $17.00 price objective on the stock. Other equities research analysts have also issued research reports about the company. HC Wainwright restated a “buy” rating and set […]
Immunic (NASDAQ:IMUX – Get Free Report)‘s stock had its “buy” rating restated by analysts at D. Boral Capital in a report issued on Thursday,Benzinga reports. They presently have a $17.00 price objective on the stock. Other equities research analysts have also issued research reports about the company. HC Wainwright restated a “buy” rating and set […]
